Skip to main content

A model system to understand immunotherapy resistance

By 18 Dicembre 2019Maggio 12th, 2021No Comments

A human model for exploring and understanding resistance to checkpoint inhibitors in cancer. We talk about it with Georgina Long (Co-Medical Director Melanoma Institute Australia, Sidney), that we met at Melanoma Bridge 2019 in Naples.